Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-290022
Filing Date
2015-08-13
Accepted
2015-08-13 16:16:11
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d913318d10q.htm 10-Q 1056443
2 EX-31.1 d913318dex311.htm EX-31.1 9569
3 EX-31.2 d913318dex312.htm EX-31.2 9543
4 EX-32.1 d913318dex321.htm EX-32.1 5331
11 GRAPHIC g913318g80n72.jpg GRAPHIC 1825
  Complete submission text file 0001193125-15-290022.txt   6922244

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bxlt-20150630.xml EX-101.INS 1508553
6 XBRL TAXONOMY EXTENSION SCHEMA bxlt-20150630.xsd EX-101.SCH 66140
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bxlt-20150630_cal.xml EX-101.CAL 103639
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bxlt-20150630_def.xml EX-101.DEF 422799
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bxlt-20150630_lab.xml EX-101.LAB 557780
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bxlt-20150630_pre.xml EX-101.PRE 497302
Mailing Address ONE BAXTER PARKWAY DEERFIELD IL 60015
Business Address ONE BAXTER PARKWAY DEERFIELD IL 60015 224-948-2000
Baxalta Inc (Filer) CIK: 0001620546 (see all company filings)

EIN.: 471869689 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36782 | Film No.: 151050900
SIC: 2834 Pharmaceutical Preparations